[Federal Register Volume 89, Number 211 (Thursday, October 31, 2024)]
[Notices]
[Pages 86829-86830]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-25335]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Mechanisms of Cancer Therapeutics.
    Date: November 21, 2024.
    Time: 1:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.

[[Page 86830]]

    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Maria Dolores Arjona Mayor, Ph.D., Scientific 
Review Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 806D, Bethesda, MD 20892, (301) 
827-8578, <a href="/cdn-cgi/l/email-protection#11757e7d7e6374623f70637b7e7f707c70687e63517f78793f767e67"><span class="__cf_email__" data-cfemail="d2b6bdbebda0b7a1fcb3a0b8bdbcb3bfb3abbda092bcbbbafcb5bda4">[email protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; RFA Panel: Investigation of Co-Occurring Conditions Across 
the Lifespan to Understand Down Syndrome.
    Date: November 22, 2024.
    Time: 9:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health Rockledge II 6701 
Rockledge Drive Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Katherine M Malinda, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4140, MSC 7814, Bethesda, MD 
20892, (301) 435-0912, <a href="/cdn-cgi/l/email-protection#620f030e0b0c0603090f220111104c0c0b0a4c050d14"><span class="__cf_email__" data-cfemail="1a777b7673747e7b71775a79696834747372347d756c">[email protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR-23-199: ClinGen Genomic Curation Expert Panels (U24).
    Date: November 25, 2024.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge, Drive Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Altaf Ahmad Dar, Ph.D., Scientific Review 
Officer, Center for Scientific Review, 6701 Rockledge Drive, 
Bethesda, MD 20892, (301) 827-2680, <a href="/cdn-cgi/l/email-protection#86e7eaf2e7e0a8e2e7f4c6e8efeea8e1e9f0"><span class="__cf_email__" data-cfemail="2849445c494e064c495a68464140064f475e">[email protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Neurotoxicology and Alcohol.
    Date: November 25, 2024.
    Time: 11:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Alexei Kondratyev, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5200, MSC 7846, Bethesda, MD 
20892, 301-435-1785, <a href="/cdn-cgi/l/email-protection#13787c7d776172676a76657277537060613d7d7a7b3d747c65"><span class="__cf_email__" data-cfemail="513a3e3f352330252834273035113222237f3f38397f363e27">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: October 25, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee 
Policy.
[FR Doc. 2024-25335 Filed 10-30-24; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>